$USNA

IIEKKING G DOUG sold $101K of USNA

IIEKKING G DOUG (CHIEF FINANCIAL OFFICER) sold 5,360 shares of USANA HEALTH SCIENCES INC (USNA) at $18.75 ($0.10M total) on 2026-05-27.

Original reporting
SEC EDGAR · IIEKKING G DOUG
Published May 28, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 8:42 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$USNA
Neutral
medium confidence
Mentioned
$USNA
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$USNANeutralLow
01

Why it matters

The newest fact is the CFO’s open-market sale details (shares, price, total value, and post-sale holdings). There is no accompanying company news such as guidance, contracts, litigation, or regulatory action.

02

Market read

Traders may note insider selling, but the disclosure alone is unlikely to drive a sustained repricing without additional fundamental catalysts.

03

What to watch

The article does not specify whether other insiders sold/bought, whether the CFO had prior large holdings, or whether there were compensatory sales that could normalize insider activity.

Relevance 4/10Novelty 3/10Timing: filed 2026-05-28 after trade dated 2026-05-27

Background

The article is a SEC Form 4 insider transaction disclosure for USANA Health Sciences, reported by its CFO.

Company-level read

Ticker impact

$USNANeutralMedium confidence
Context

USANA CFO sold 5,360 shares in an open-market transaction for about $100.5K, leaving 0 shares after the trade.

Expected impact

Likely limited near-term impact; any reaction would be sentiment-driven rather than fundamental.

Evidence & confidence

The filing is a Form 4 insider transaction. The article provides trade size, price, and post-transaction holdings, but no earnings, guidance, or operational change.

Market effects

No clear sector read-through from a single, small CFO sale.

None indicated.

None indicated.

Counterpoint

The sale could be for diversification, taxes, or planned liquidity needs, especially since the filing does not indicate any operational issue.

Key entities

  • USANA HEALTH SCIENCES INC

    Company whose CFO executed an open-market sale disclosed on Form 4.

  • IIEKKING G DOUG

    Chief Financial Officer who sold 5,360 shares at $18.7525 on 2026-05-27.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$USNAMedAI 8/10

USANA (USNA) Q2 2026 Earnings Call Transcript

USANA (USNA) held its Q2 2026 earnings call. Management said Core Nutritional was stable, with Mainland China showing renewed strength. The company recorded a preliminary $29 million noncash goodwill impairment and $9 million income tax expense on a $19 million pretax loss. USANA ended the quarter with $169 million cash, zero debt, and $20 million free cash flow, and lowered its fiscal 2026 outlook due to HYA DTC marketing and Rise net sales.

$USNAMedAI 8/10

USANA Health Sciences Q2 Earnings Call Highlights

USANA Health Sciences (NYSE:USNA) reported Q2 updates including a $29 million preliminary non-cash goodwill impairment tied to its Hiya reporting unit and $9 million income tax expense on a $19 million pre-tax loss. Management cited about $30 million to $40 million top-line pressure and $4 million to $5 million margin pressure, plus a Rise packaging disruption. USANA ended with $169 million cash and no debt.

$USNAHighAI 9/10

Why Usana Health Sciences Stock Plummeted This Week

Usana Health Sciences (USNA) shares fell about 30% after its Aug. 4 Q2 results missed expectations and guidance disappointed. The company reported non-GAAP EPS of $0.07 on about $223M sales, with sales and profit below analyst averages. It also took a $29M goodwill impairment on Hiya, cut 2024 guidance to an $11M loss and lowered sales to $910M from $925M-$1B.

$USNAHigh

USANA HEALTH SCIENCES INC (USNA): Results of Operations and Financial Condition

USANA HEALTH SCIENCES INC (USNA) filed an SEC Form 8-K — Results of Operations and Financial Condition. USANA Health Sciences Reports Second Quarter 2026 Results Company Continues Evolution to a Diversified, Omnichannel Health and Wellness Business SALT LAKE CITY, August 4, 2026 (BUSINESS WIRE)—USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fisca